The largest database of trusted experimental protocols

3 protocols using alexa fluor 647 conjugated antibody

1

Quantifying SARS-CoV-2 Pseudovirus Infectivity

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the infectious units and infection rates of SARS-CoV-2 pseudovirus, we plated 400,000 293T-ACE2 cells per well of a 12-well plate. SARS-CoV-2 pseudovirus supernatants that were produced in parallel under identical conditions (as described above) were added 24 h later in three ten-fold serial dilutions. Cells were incubated for 48 h at 37°C/5% CO2 to allow for expression of ZsGreen reporter gene and harvested with Trypsin-EDTA (Corning). Cells were resuspended in PBS supplemented with 2% FBS (PBS+), and analyzed on a Stratedigm S1300Exi Flow Cytometer to determine the percentage of ZsGreen+ cells. Infectious units were calculated by determining the percentage of infected cells in wells exhibiting linear decreases in transduction and multiplying by the average number of cells per well determined at the initiation of the assay. At low MOI (infection rates <10%), each transduced ZsGreen+ cell was assumed to represent a single infectious unit. Surface expression of ACE2 on 293T and 293T-ACE2 cells was confirmed by staining with 1 μL of anti-human ACE2, Alexa Fluor 647-conjugated antibody (R&D). Cells were incubated for 10 min at 25°C prior to running on a Stratedigm S1300Exi Flow Cytometer.
+ Open protocol
+ Expand
2

Evaluating CAR Activation in NFAT-GFP Hybridoma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CAR constructs were tested in vitro in a murine NFAT-GFP hybridoma cell line that encoded GFP under the control of an NFAT-dependent IL-2 promoter [32 (link)]. Transduction of the hybridoma cells was performed as described in Section 2.5. HEK293T cells were transfected with the TSPAN7 antigen vector to express the target antigen. TSPAN7 expression was verified with flow cytometry staining with an anti-TSPAN7 Alexa Fluor™ 647-conjugated antibody (FAB9179R, R&D Systems, Wiesbaden, Germany). After 48 h, hybridoma cells were either activated in TSPAN7 protein- or peptide-coated wells, or mixed with antigen-expressing HEK293T cells in 48-well culture plates (677 180, Greiner Bio-One). After 24 h, the cells were harvested and stained with an anti-Fab fragment Alexa Fluor 647-conjugated antibody (109-605-006; Jackson ImmunoResearch, West Grove, PA, USA) for CAR expression and an anti-Her-2 PE-conjugated antibody (324405; BioLegend) for negative gating of HEK293T cells. Cells were analyzed by flow cytometry for the HEK293T marker (PE), CAR expression (Alexa Fluor™ 647), and CAR activation (endogenous GFP).
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry of CAR-T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human HER2 and PD-L1 expression on tumor cells was detected using human HER2-PE-CY7 (clone 24D2, Biolegend) and PD-L1-APC (clone MIH1, eBioscience). HER2 4D5 CAR was detected using the anti-trastuzumab idiotype Alexa Fluor 647-conjugated antibody (clone 2661E, R&D system). HER2 4D5 CAR was also detected using human recombinant HER2 protein conjugated with Alex Fluor 647. Human T cells surface phenotype and transduction efficiency were assessed using the following antibodies: NGFR-FITC (clone ME20.4, Biolegend), Q8 (clone QBEND/10, ThermoFisher), CD45-AF700 or CD45-BV605 (clone HI30, Biolegend), CD3-APC (clone SK7, Biolegend), CD4-PerCP (clone SK3, Biolegend), CD4-BB700 (clone SK3, BD Bioscience), CD8-BV510 (clone SK1, Biolegend), CD27-PE-CY7 (clone M-T271, Biolegend), CD28-BV605 (clone CD28.2, Biolegend. Expression of T cell inhibitory receptors was analyzed using PD-1-BV421 or PD-1-BV605 (clone EH12.2H7, Biolegend), TIM-3-BV605 or TIM-3-PE-CY-7 (clone F38-2E2, Biolegend), CD39 (clone A1, Biolegend), LAG-3-BV711 (clone 11C3C65, Biolegend). Live/dead discrimination was determined using LIVE/DEAD fixable Near-IR dead cell stain kit (ThermoFisher). Flow cytometry results were analyzed using Kaluza software (Beckman Coulter).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!